Zilico Ltd is a UK based company which specialises in the design and manufacture of real-time medical diagnostics to address specific clinical needs.
ZedScan™, Zilico's pioneering flagship product utilises Electrical Impedance Spectroscopy (EIS) to improve the ability to detect cervical intraepithelial neoplasia (CIN) following an abnormal smear result, increasing diagnostic accuracy and delivering health economic benefits.
Zilico’s patented EIS technology exploits the different electrical resistivity associated with the cellular structure of normal, pre-cancerous and cancerous tissue, which based on its applicability to other types of neoplasia, substantiates its use as a platform for the rapid, reliable and reproducible detection and diagnosis of disease.
ZedScan™, Zilico's pioneering flagship product utilises Electrical Impedance Spectroscopy (EIS) to improve the ability to detect cervical intraepithelial neoplasia (CIN) following an abnormal smear result, increasing diagnostic accuracy and delivering health economic benefits.
Zilico’s patented EIS technology exploits the different electrical resistivity associated with the cellular structure of normal, pre-cancerous and cancerous tissue, which based on its applicability to other types of neoplasia, substantiates its use as a platform for the rapid, reliable and reproducible detection and diagnosis of disease.
Location: United Kingdom, England, Manchester
Employees: 11-50
Total raised: $20.54M
Founded date: 2006
Investors 2
| Date | Name | Website |
| - | Venture Fo... | venturefou... |
| - | Harwell Ca... | harwellcap... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 02.02.2018 | - | $19M | - |
| 21.06.2012 | - | $1.54M | The North ... |
Mentions in press and media 2
| Date | Title | Description |
| 02.02.2018 | Zilico Raises $19M in Total Investments | Zilico, a Manchester, UK-based developer of a cervical cancer diagnostic system, raised a $19m in total funding. The company will receive minimum royalties of $12m and investments totalling $7M. Backers included the MaxHealth Medicine Group... |
| 21.06.2012 | Zilico Receives £985K in Funding | Zilico Limited, a Sheffield, UK-based company that has developed a technology to speed up and improve cervical cancer diagnosis, has received £985k in funding. Backers include The North West Fund for Biomedical, managed by SPARK Impact, whi... |